BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
Business Of Biotech
00:00
Is It a Shortage in Skill and Experience?
I think it's skill and experience of doing it because we haven't been doing self therapy for that long. A lot of the people that are now in the manufacturing space are repurposed monoclonal or vaccine people. The question I often get asked is, is the FDA now being much more strict and less supportive of self therapy? I always say no and I think the FDA is doing a fantastic job. What we're witnessing is what were great ideas on paper going through pre-IND studies and all the practicalities of making a drug which is making it much more complicated than anyone understands.
Transcript
Play full episode
